Cargando…
Carbon Nanotubes as Carriers in Drug Delivery for Non-Small Cell Lung Cancer, Mechanistic Analysis of Their Carcinogenic Potential, Safety Profiling and Identification of Biomarkers
Non-small cell lung cancer (NSCLC) is a global burden leading to millions of deaths worldwide every year. Nanomedicine refers to the use of materials at the nanoscale for drug delivery and subsequent therapeutic approaches in cancer. Carbon nanotubes (CNTs) are widely used as nanocarriers for therap...
Autores principales: | Pu, Zhongjian, Wei, Yujia, Sun, Yuanpeng, Wang, Yajun, Zhu, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744892/ https://www.ncbi.nlm.nih.gov/pubmed/36523423 http://dx.doi.org/10.2147/IJN.S384592 |
Ejemplares similares
-
Biocompatibility and Carcinogenicity of Carbon Nanotubes as Biomaterials
por: Aoki, Kaoru, et al.
Publicado: (2020) -
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
por: Zare, Hossein, et al.
Publicado: (2021) -
Assessment of the Carcinogenicity of Carbon Nanotubes in the Respiratory System
por: Barbarino, Marcella, et al.
Publicado: (2021) -
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]
Publicado: (2021) -
Carbon Nanotubes—Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
por: Kofoed Andersen, Camilla, et al.
Publicado: (2021)